- Home
- JZXN vs ALLR Comparison
JZXN vs ALLR Comparison
Compare JZXN & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- ALLR
- Stock Information
- Founded
- JZXN 2019
- ALLR 2004
- Country
- JZXN China
- ALLR United States
- Employees
- JZXN N/A
- ALLR N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- ALLR Health Care
- Exchange
- JZXN Nasdaq
- ALLR Nasdaq
- Market Cap
- JZXN 21.8M
- ALLR 20.2M
- IPO Year
- JZXN 2021
- ALLR N/A
- Fundamental
- Price
- JZXN $0.27
- ALLR $1.23
- Analyst Decision
- JZXN
- ALLR Strong Buy
- Analyst Count
- JZXN 0
- ALLR 1
- Target Price
- JZXN N/A
- ALLR $9.25
- AVG Volume (30 Days)
- JZXN 10.2M
- ALLR 292.3K
- Earning Date
- JZXN 03-05-2026
- ALLR 11-14-2025
- Dividend Yield
- JZXN N/A
- ALLR N/A
- EPS Growth
- JZXN N/A
- ALLR N/A
- EPS
- JZXN N/A
- ALLR N/A
- Revenue
- JZXN $97,465.00
- ALLR N/A
- Revenue This Year
- JZXN N/A
- ALLR N/A
- Revenue Next Year
- JZXN N/A
- ALLR N/A
- P/E Ratio
- JZXN N/A
- ALLR N/A
- Revenue Growth
- JZXN N/A
- ALLR N/A
- 52 Week Low
- JZXN $0.25
- ALLR $0.61
- 52 Week High
- JZXN $7.82
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- JZXN 34.41
- ALLR 36.00
- Support Level
- JZXN $0.27
- ALLR $1.34
- Resistance Level
- JZXN $0.39
- ALLR $1.45
- Average True Range (ATR)
- JZXN 0.05
- ALLR 0.09
- MACD
- JZXN 0.02
- ALLR -0.02
- Stochastic Oscillator
- JZXN 8.67
- ALLR 4.62
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.